Medicine and Dentistry
Anagliptin
100%
Intracranial Aneurysm
77%
Macrophage
66%
Dipeptidyl Peptidase-4 Inhibitor
55%
Monocyte Chemotactic Protein 1
33%
Growth
33%
Phosphotransferase
33%
Antiinflammatory Activity
33%
Aneurysm
33%
Phosphorylation
22%
Lipopolysaccharide
22%
Interleukin 6
22%
Cells
11%
Tumor Necrosis Factor
11%
Serositis
11%
Pathogenesis
11%
Therapeutic Procedure
11%
In Vitro
11%
Morphology
11%
Chronic Inflammation
11%
Mediator
11%
Oral Drug Administration
11%
Glucagon Like Peptide 1
11%
Male
11%
Antidiabetic Activity
11%
Pharmacology, Toxicology and Pharmaceutical Science
Anagliptin
100%
Intracranial Aneurysm
77%
Dipeptidyl Peptidase IV Inhibitor
55%
Monocyte Chemotactic Protein 1
33%
Phosphotransferase
33%
Aneurysm
33%
Interleukin 6
22%
Lipopolysaccharide
22%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
11%
Inflammation
11%
Sprague Dawley Rat
11%
Pathogenesis
11%
Tumor Necrosis Factor
11%
Glucagon-Like Peptide-1
11%
Chronic Inflammation
11%
Rodent
11%